These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28934253)

  • 61. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hypocholesterolemic effect of stilbene extract from Cajanus cajan L. on serum and hepatic lipid in diet-induced hyperlipidemic mice].
    Luo QF; Sun L; Si JY; Chen DH; Du GH
    Yao Xue Xue Bao; 2008 Feb; 43(2):145-9. PubMed ID: 18507340
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T; Zhu J; Zhu L; Cheng M
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms.
    Garelnabi M; Selvarajan K; Litvinov D; Santanam N; Parthasarathy S
    Atherosclerosis; 2008 Aug; 199(2):304-9. PubMed ID: 18243209
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet.
    Wan CW; Wong CN; Pin WK; Wong MH; Kwok CY; Chan RY; Yu PH; Chan SW
    Phytother Res; 2013 Apr; 27(4):545-51. PubMed ID: 22674675
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats.
    Roglans N; Vilà L; Farré M; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
    Hepatology; 2007 Mar; 45(3):778-88. PubMed ID: 17326204
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators.
    Vu-Dac N; Gervois P; Jakel H; Nowak M; Bauge E; Dehondt H; Staels B; Pennacchio LA; Rubin EM; Fruchart-Najib J; Fruchart JC
    J Biol Chem; 2003 May; 278(20):17982-5. PubMed ID: 12637506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of polyphenol-rich extract from walnut on diet-induced hypertriglyceridemia in mice via enhancement of fatty acid oxidation in the liver.
    Shimoda H; Tanaka J; Kikuchi M; Fukuda T; Ito H; Hatano T; Yoshida T
    J Agric Food Chem; 2009 Mar; 57(5):1786-92. PubMed ID: 19256553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
    Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Regulatory functions of electroacupuncture at fenglong (ST40) on blood lipids and hepatic ABCA1 and PPARalpha in hyperlipidemia rats].
    Wang Q; Huang H; Yue W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1245-8. PubMed ID: 23185768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glucose regulates the expression of the apolipoprotein A5 gene.
    Nowak M; Helleboid-Chapman A; Jakel H; Moitrot E; Rommens C; Pennacchio LA; Fruchart-Najib J; Fruchart JC
    J Mol Biol; 2008 Jul; 380(5):789-98. PubMed ID: 18572192
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phytol directly activates peroxisome proliferator-activated receptor alpha (PPARalpha) and regulates gene expression involved in lipid metabolism in PPARalpha-expressing HepG2 hepatocytes.
    Goto T; Takahashi N; Kato S; Egawa K; Ebisu S; Moriyama T; Fushiki T; Kawada T
    Biochem Biophys Res Commun; 2005 Nov; 337(2):440-5. PubMed ID: 16202384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy and safety of simvastatin in Asian and non-Asian coronary heart disease patients: a comparison of the GOALLS and STATT studies.
    Morales D; Chung N; Zhu JR; Sangwatanaroj S; Yin WH; Lee K; Davies MJ; Shah A; Loeys T; Bilheimer D
    Curr Med Res Opin; 2004 Aug; 20(8):1235-43. PubMed ID: 15324526
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
    Goto T; Kim YI; Funakoshi K; Teraminami A; Uemura T; Hirai S; Lee JY; Makishima M; Nakata R; Inoue H; Senju H; Matsunaga M; Horio F; Takahashi N; Kawada T
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E1022-32. PubMed ID: 21862726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.
    Feng Q; Baker SS; Liu W; Arbizu RA; Aljomah G; Khatib M; Nugent CA; Baker RD; Forte TM; Hu Y; Zhu L
    Pathology; 2015 Jun; 47(4):341-8. PubMed ID: 25938357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-III.
    Liu C; Guo Q; Lu M; Li Y
    Eur J Pharmacol; 2015 Aug; 761():362-74. PubMed ID: 25979856
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.
    Nowak M; Helleboid-Chapman A; Jakel H; Martin G; Duran-Sandoval D; Staels B; Rubin EM; Pennacchio LA; Taskinen MR; Fruchart-Najib J; Fruchart JC
    Mol Cell Biol; 2005 Feb; 25(4):1537-48. PubMed ID: 15684402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.